Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05234372 · ClinicalTrials.gov registry record · NA
MiVacunaLA: an Intervention to Improve COVID-19 Vaccination Behaviors Among Latinos
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 468
- Enrollment target
NCT05234372 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 468 participants.
The verdict
NCT05234372, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 468 participants
- Enrollment target
Study Summary
The aim of this study is to determine whether a community-informed, linguistically and culturally tailored educational program delivered via mobile phone is effective in improving vaccination behaviors among Latino families. Thus we evaluate a community-based mobile phone intervention (mivacunaLA) to assess if there is an increase in vaccination rates among 12-17 year old children and willingness to vaccinate 2-11year old children who have not been previously vaccinated who reside in high-risk and low resourced neighborhoods in Los Angeles.
Interventions
- BEHAVIORAL mivacunaLA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 468 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05234372
The ClinicalTrials.gov registry entry for NCT05234372 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 468 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mivacunaLA is the first listed.
NCT05234372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05234372 about?
NCT05234372 is a clinical study titled "MiVacunaLA: an Intervention to Improve COVID-19 Vaccination Behaviors Among Latinos". The aim of this study is to determine whether a community-informed, linguistically and culturally tailored educational program delivered via mobile phone is effective in improving vaccination behaviors among Latino families. Thus we evaluate a community-based mobile phone intervention (mivacunaLA) t...
What is the current status of trial NCT05234372?
This trial is currently completed. It is a NA study. The enrollment target is 468 participants. The study started on 2022-06-01. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT05234372?
The interventions under investigation include: mivacunaLA (BEHAVIORAL).
Who is sponsoring clinical trial NCT05234372?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.